Antioxidants and ischaemic heart disease (vol 350, pg 667, 1997)

被引：0

作者：

Iuliano, L

机构：

来源：

LANCET | 1997年 / 350卷 / 9092期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1712 / 1712

页数：1

相关论文

共 50 条

[21] Why ''underpowered'' trials are not necessarily unethical (vol 350, pg 804, 1997)
Edwards, SJL
LANCET, 1997, 350 (9091) : 1636 - 1636
[22] Management of patients with acute ischaemic stroke (vol 54, pg 62, 1997)
Adams, HP
DRUGS, 2000, 59 (03) : 476 - 476
[23] β-casein A, ischaemic heart disease mortality, and other illnesses (vol 56, pg 262, 2001)
McLachlan, CNS
MEDICAL HYPOTHESES, 2001, 56 (03) : 413 - 413
[24] Nifedipine and coronary heart disease: Reasons for controversy (vol 52, pg 37, 1997)
Lievre, M
Cucherat, M
THERAPIE, 1997, 52 (03): : 239 - 240
[25] Responses of antioxidants to paraquat in pea leaves (vol 113, pg 249, 1997)
Donahue, JL
Okpodu, CM
Cramer, CL
Grabau, EA
Alscher, RG
PLANT PHYSIOLOGY, 1997, 113 (03) : 1007 - 1007
[26] Poppy Tea and the baker's first seizure (vol 350, pg 716, 1997)
King, MA
LANCET, 1997, 350 (9085) : 1182 - 1182
[27] Nephrogenic diabetes insipidus in a patient taking cidofovir (vol 350, pg 413, 1997)
Schliefer, K
LANCET, 1997, 350 (9090) : 1558 - 1558
[28] Bisphosphonates for pain relief in reflex sympathetic dystrophy (vol 350, pg 1117, 1997)
Schott, GD
LANCET, 1998, 351 (9103) : 682 - 682
[29] Usefulness of Cystatin C in the Postoperative Management of Pediatric Patients With Congenital Heart Disease (vol 77, pg 667, 2013)
Yana, Akiko
Masutani, Satoshi
Kojima, Takuro
Saiki, Hirofumi
Taketazu, Mio
Tamura, Masanori
Senzaki, Hideaki
CIRCULATION JOURNAL, 2014, 78 (05) : 1266 - 1266
[30] Cracovian program for secondary prevention of ischaemic heart disease - Secondary prevention of ischaemic heart disease during hospitalisation in 1996/1997 and 1998/1999
Kawecka-Jaszcz, K
Jankowski, P
Pajak, A
Dubiel, JS
Maciejewicz, J
Piotrowski, W
Smielak-Korombel, W
Tracz, W
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2004, 6 (0J) : J47 - J52

← 1 2 3 4 5 →